Jinyu Bio-technology (600201.SH) announced that in order to promote the company's global strategy and promote the biomedical industry in Inner Mongolia Autonomous Region, and achieve regional economic transformation and upgrading, the company has signed a partnership agreement with Inner Mongolia Financial Asset Management Co., Ltd. ("Inner Mongolia Capital") and Inner Mongolia New Energy Fund Management Co., Ltd. ("New Energy Fund") to initiate the establishment of a private equity investment fund named Inner Mongolia Jinxin No.1 Equity Fund Management Partnership (Limited Partnership).
Jinyu Bio-technology (600201.SH) announced that in order to promote the company's global strategy and promote the biomedical industry in Inner Mongolia Autonomous Region, and achieve regional economic transformation and upgrading, the company has signed a partnership agreement with Inner Mongolia Financial Asset Management Co., Ltd. ("Inner Mongolia Capital") and Inner Mongolia New Energy Fund Management Co., Ltd. ("New Energy Fund") to initiate the establishment of a private equity investment fund named Inner Mongolia Jinxin No.1 Equity Fund Management Partnership (Limited Partnership).
The total subscribed capital of the first phase of the fund is RMB 0.5 billion, and Jinyu Bio-technology and its subsidiary Jinyu Baoling Biotechnology Research Institute ("Baoling Research Institute") plan to subscribe for RMB 0.2 billion.
The participation in the establishment of the biomedical industry investment fund is a forward-looking layout for the company's global strategy, and plans to focus on the company's main business, leverage the investment experience of professional investment institutions, effectively grasp the development opportunities of the biopharmaceutical industry, achieve the company's transformation and upgrading, and achieve sustainable and healthy development, to enhance shareholder returns.